These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26832957)

  • 1. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.
    Ghosh A; Miller W; Orchard PJ; Jones SA; Mercer J; Church HJ; Tylee K; Lund T; Bigger BW; Tolar J; Wynn RF
    Mol Genet Metab; 2016 Mar; 117(3):373-7. PubMed ID: 26832957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.
    Hampe CS; Wesley J; Lund TC; Orchard PJ; Polgreen LE; Eisengart JB; McLoon LK; Cureoglu S; Schachern P; McIvor RS
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.
    Eisengart JB; Rudser KD; Xue Y; Orchard P; Miller W; Lund T; Van der Ploeg A; Mercer J; Jones S; Mengel KE; Gökce S; Guffon N; Giugliani R; de Souza CFM; Shapiro EG; Whitley CB
    Genet Med; 2018 Nov; 20(11):1423-1429. PubMed ID: 29517765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.
    Shapiro EG; Nestrasil I; Rudser K; Delaney K; Kovac V; Ahmed A; Yund B; Orchard PJ; Eisengart J; Niklason GR; Raiman J; Mamak E; Cowan MJ; Bailey-Olson M; Harmatz P; Shankar SP; Cagle S; Ali N; Steiner RD; Wozniak J; Lim KO; Whitley CB
    Mol Genet Metab; 2015; 116(1-2):61-8. PubMed ID: 26095521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.
    Pillai NR; Elsbecker SA; Gupta AO; Lund TC; Orchard PJ; Braunlin E
    Mol Genet Metab; 2023 Nov; 140(3):107669. PubMed ID: 37542767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
    Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
    Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hurler Syndrome Glycosaminoglycans Decrease in Cerebrospinal Fluid without Brain-Targeted Therapy.
    Lund TC; Braunlin E; Polgreen LE; Gupta AO; Orchard PJ; Eisengart JB
    Ann Neurol; 2023 Dec; 94(6):1182-1186. PubMed ID: 37679306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawn: Role of Haematopoietic Stem Cell Transplantation in management of Severe Chronic Neutropenia.
    Curr Drug Targets; 2018 Mar; ():. PubMed ID: 29521225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome.
    Eisengart JB; Jarnes J; Ahmed A; Nestrasil I; Ziegler R; Delaney K; Shapiro E; Whitley C
    Mol Genet Metab Rep; 2017 Dec; 13():64-68. PubMed ID: 28983455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation.
    Lum SH; Stepien KM; Ghosh A; Broomfield A; Church H; Mercer J; Jones S; Wynn R
    J Inherit Metab Dis; 2017 May; 40(3):455-460. PubMed ID: 28283844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.
    Rodgers NJ; Kaizer AM; Miller WP; Rudser KD; Orchard PJ; Braunlin EA
    J Inherit Metab Dis; 2017 Mar; 40(2):271-280. PubMed ID: 28054207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I.
    Ghosh A; Mercer J; Mackinnon S; Yue WW; Church H; Beesley CE; Broomfield A; Jones SA; Tylee K
    Hum Mutat; 2017 Nov; 38(11):1555-1568. PubMed ID: 28752568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
    da Silva EM; Strufaldi MW; Andriolo RB; Silva LA
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008185. PubMed ID: 26845288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome.
    Yuan C; Bothun ED; Hardten DR; Tolar J; McLoon LK
    Exp Eye Res; 2016 Jul; 148():83-89. PubMed ID: 27235795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.
    Schmidt M; Breyer S; Löbel U; Yarar S; Stücker R; Ullrich K; Müller I; Muschol N
    Orphanet J Rare Dis; 2016 Jul; 11(1):93. PubMed ID: 27392569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.
    Lin HY; Chuang CK; Chen MR; Lin SM; Hung CL; Chang CY; Chiu PC; Tsai WH; Niu DM; Tsai FJ; Lin SJ; Hwu WL; Lin JL; Lin SP
    Mol Genet Metab; 2016 Apr; 117(4):431-7. PubMed ID: 26899310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I.
    Nestrasil I; Shapiro E; Svatkova A; Dickson P; Chen A; Wakumoto A; Ahmed A; Stehel E; McNeil S; Gravance C; Maher E
    Am J Med Genet A; 2017 Mar; 173(3):780-783. PubMed ID: 28211988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients.
    Smid BE; Ferraz MJ; Verhoek M; Mirzaian M; Wisse P; Overkleeft HS; Hollak CE; Aerts JM
    Orphanet J Rare Dis; 2016 Mar; 11():28. PubMed ID: 27008851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
    Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
    J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.